Current Ratio of Mersana Therapeutics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Mersana Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Mersana Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 172%, a 42% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Mersana Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 172% -124% -42% 30 Sep 2025
Q2 2025 195% -137% -41% 30 Jun 2025
Q1 2025 228% -137% -38% 31 Mar 2025
Q4 2024 265% -94% -26% 31 Dec 2024
Q3 2024 295% -66% -18% 30 Sep 2024
Q2 2024 332% -22% -6.2% 30 Jun 2024
Q1 2024 365% +25% +7.5% 31 Mar 2024
Q4 2023 360% +4% +1% 31 Dec 2023
Q3 2023 361% -5% -1.3% 30 Sep 2023
Q2 2023 354% -41% -10% 30 Jun 2023
Q1 2023 340% -118% -26% 31 Mar 2023
Q4 2022 356% -155% -30% 31 Dec 2022
Q3 2022 366% -252% -41% 30 Sep 2022
Q2 2022 395% -395% -50% 30 Jun 2022
Q1 2022 458% -520% -53% 31 Mar 2022
Q4 2021 511% -487% -49% 31 Dec 2021
Q3 2021 618% -266% -30% 30 Sep 2021
Q2 2021 790% +105% +15% 30 Jun 2021
Q1 2021 978% +491% +101% 31 Mar 2021
Q4 2020 999% +473% +90% 31 Dec 2020
Q3 2020 884% +550% +165% 30 Sep 2020
Q2 2020 685% +388% +131% 30 Jun 2020
Q1 2020 487% +225% +86% 31 Mar 2020
Q4 2019 526% +293% +125% 31 Dec 2019
Q3 2019 334% -4% -1.3% 30 Sep 2019
Q2 2019 297% -101% -25% 30 Jun 2019
Q1 2019 262% -118% -31% 31 Mar 2019
Q4 2018 233% 31 Dec 2018
Q3 2018 338% 30 Sep 2018
Q2 2018 398% 30 Jun 2018
Q1 2018 380% 31 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.